South Africa, PATH, and Wellcome launch world’s first AI framework for mental health at G20 Social Summit
[Embargoed] Johannesburg, 19 November 2025 – As ar
19 November, 2025SAHPRA warns the public about GLP-1 products sold through social media platforms
Pretoria, 11 November 2025 – The South African Hea
12 November, 2025SAHPRA Registers Lenacapavir
Pretoria, 27 October 2025 – The South African Heal
27 October, 2025SAHPRA clarifies that paracetamol is safe to use in pregnancy, at recommended doses
Pretoria, 28 September 2025 – The South African He
28 September, 2025SAHPRA Approves Mpox Test Using AMRH Continental EUL Procedure
Pretoria, 27 August 2025 –The South African Health
27 August, 2025SAHPRA‘s position on anti-cancer medications in South Africa
Pretoria, 15 July 2025 – The South African Health
15 July, 2025SAHPRA alerts the public about fake licence holders
Pretoria, 11 June 2025—The South African Health Pr
11 June, 2025SAHPRA Approves First WHO EUL Mpox Test Kit
Pretoria, 22 May 2025 –The South Af
22 May, 2025SAHPRA joins the Medical Device Single Audit Programme
Pretoria, 04 April 2025 –The South African Health
04 April, 2025SAHPRA clarifies the benefits and risks of medroxyprogesterone acetate
Pretoria, 17 January 2025 – The South African Heal
17 January, 2025SAHPRA Offices will be unavailable on 29 November 2024
Please note that SAHPRA Head Office, including Cap
29 November, 2024SAHPRA office closure during the 2024 festive season
SAHPRA offices will be closed for the festive seas
22 November, 2024SAHPRA recalls a batch of YAZ Plus contraceptives due to a quality issue
Pretoria, 21 November 2024 – The South African Hea
21 November, 2024SAHPRA’s position on GLP1 and GIP-GLP1 products that are compounded, substandard and falsified
Pretoria, 08 November 2024 –The South African Heal
08 November, 2024SAHPRA encourages the safe use of medicines and reporting of suspected side effects this #MedSafetyWeek
Pretoria, 07 November 2024 – The South African Hea
07 November, 2024South African and Australian health product regulators to share regulatory information and expertise
Pretoria, South Africa and Canberra, Australia, 07
07 October, 2024SAHPRA attains clean audit outcome for the 2023/2024 financial year
Pretoria, 16 September 2024 –The South African Hea
16 September, 2024SAHPRA dismisses unfounded misinformation campaign deliberately misrepresenting its draft B-BBEE Policy by some sectors of society and media organisations
Pretoria, 22 July 2024 –The South African Health P
22 July, 2024SAHPRA CEO delivers keynote address at 2024 SAAPI Conference
The South African Association of Pharmacists in In
24 June, 2024SAHPRA releases results of investigation following recall of Benylin Paediatric syrup
Pretoria, 05 June 2024 –On 13 April 2024, the Sout
05 June, 2024SAHPRA attains ISO 9001 Certification as confirmation of its robust quality management processes
Pretoria, 29 May 2024 –The South African Health Pr
28 May, 2024SAHPRA and Botswana Medicines Authority partner to enhance medicines regulation in the region
Pretoria, South Africa, 28 April 2024 – The South
28 April, 2024SAHPRA recalls two batches of Benylin Paediatric Syrup
Pretoria, 13 April 2024 – On 10 April 2024, the So
13 April, 2024SAHPRA signs MoU with Rwanda Food and Drug Authority
Kigali – Rwanda, 12 April 2024 – The South A
12 April, 2024SAHPRA invests in patient safety – announcing new graduates
The South Africa Health Products Regulatory Author
04 April, 2024Pretoria High Court Judgement on COVID-19 Vaccinations
Pretoria, 11 March 2024 – On 05 January 2023, the
11 March, 2024Department Dismisses Social Media Video on Covid-19 Vaccine Deaths
Pretoria, 19 February 2024 – The Department of Hea
19 February, 2024SAHPRA signs MoU with Medicines Control Authority of Zimbabwe
Pretoria, 12 January 2024 – The South African Heal
12 January, 2024SAHPRA recalls Lubri-A, sterile lubricating gel
Pretoria, 19 December 2023 – The South African Hea
20 December, 2023SAHPRA invests in capacity building with a focus on patient safety
Pretoria, 14 December 2023 -The South Africa Healt
14 December, 2023SAHPRA’s position on Semaglutide compounded products
Pretoria, 13 December 2023 – The South African Hea
13 December, 2023Public urged to use registered Ozempic products
Pretoria, 11 December 2023 – The South African Hea
11 December, 2023Update on COVID-19 vaccines
Pretoria, 26 October 2023 – The South African Heal
26 October, 2023SAHPRA aware of Illicit bulk sales of codeine-containing mixtures exposed by Carte Blanche
Pretoria, 10 October 2023 –The South African Healt
10 October, 2023USP welcomes Executive Delegation from SAHPRA
August 30, 2023, Rockville, MD – United States Pha
31 August, 2023Africa CDC donates equipment to SAHPRA to support regulatory functions in vaccine manufacturing
Pretoria, 10 August 2023 – The Africa Centre for D
10 August, 2023SCA Judgement Ruling
The South Africa Health Products Regulatory Author
02 August, 2023SAHPRA signs MOU with Egyptian Drug Authority
Pretoria, 11 July 2023 -The South Africa Health Pr
11 July, 2023SAHPRA invests in capacity building – announcing new graduates
The South Africa Health Products Regulatory Author
05 June, 2023Executive Forecast: In Conversation with Dr. Boitumelo Semete-Makokotlela
Pretoria, 29 May 2023 EF: If you had to desi
29 May, 2023SAHPRA perspectives on Coronavirus SARS-COV-2
Pretoria, 15 May 2023 -The South Africa Health Pro
15 May, 2023COVID-19 Vaccine Janssen update – Third fatal case of Guillain-Barré syndrome
Pretoria, 21 April 2023 – The South African
21 April, 2023SAHPRA withdraws pholcodine-containing medicines from SA market
Pretoria, 06 April 2023 – The South African Health
06 April, 2023SAHPRA registers Paxlovid, an anti-viral medicine for COVID-19
Pretoria, 30 January 2023 – The South African Heal
30 January, 2023SAHPRA registers new long-acting HIV Pre-exposure prophylaxis
Pretoria, 2 December 2022 – The South African Heal
02 December, 2022SAHPRA celebrates the conclusion of the backlog clearance project
Pretoria, 2 December 2022 – With the establishment
02 December, 2022SAHPRA approves antigen self-test kits for public use
Pretoria, 24 November 2022 – In the past year, the
24 November, 2022SAHPRA Statement – Latest Development on Ivermectin Court Case
Pretoria, 23 November 2022 – On 6 April 2021, the
23 November, 2022SAHPRA registers COMIRNATY’s paediatric and adult vaccines
22 November 2022 Embargo: Immediate release Pretor
22 November, 2022SAHPRA receives Accolade from the National Press Club (NPC)
Pretoria, 4 November 2022 – The South African Heal
04 November, 2022SAHPRA is investigating Tembisa Hospital procurement of health products
Pretoria, 4 November 2022 – The South African Heal
04 November, 2022SAHPRA alerts the public about contaminated health products
Pretoria, 10 October 2022 – The South African Heal
10 October, 2022SAHPRA receives Accolade from the World Health Organisation
Pretoria, 5 October 2022 – The South African
05 October, 2022Update on COVID-19 health products
UPDATE ON COVID-19 HEALTH PRODUCTS: SAHPRA registe
28 September, 2022COVID-19 Vaccine Janssen update – Second fatal case of Guillain-Barré syndrome
Pretoria, 12 September 2022 – On the 04th of
12 September, 2022Update on COVID-19 Vaccine Janssen – Guillain-Barré syndrome
04 August 2022 On 31 March 2021, SAHPRA approved t
04 August, 2022SAHPRA clarifies process for importation of medicines
Embargo: Immediate release Pretoria, 20 July 2022
20 July, 2022
Health Product literacy top of mind as SAHPRA announces online medicines directory
28 June 2022 The South African Health Products Aut
28 June, 2022SAHPRA registers the COVID-19 vaccine, Coronavac
Embargo: Immediate release Pretoria, 24 June 2022
24 June, 2022SAHPRA Announces Approval of Breakthrough Treatments for Children with HIV
Embargo: Immediate release Pretoria, 23 June 2022
23 June, 2022SAHPRA registers a vaccine and provides emergency use authorisation of health products in the fight against COVID-19
07 June 2022 Embargo: Immediate release1. The COVI
07 June, 2022SAHPRA statement on the termination of the “Ivermectin Controlled Compassionate Use Access Programme”
30 May 2022 Embargo: Immediate release Pretoria, 3
30 May, 2022Update: SAHPRA Statement on the ANHP Judgement
27 May 2022 Embargo: Immediate release On 7 May 20
27 May, 2022Safety of the COVID-19 Vaccine Janssen – response to restrictions imposed in the United States
12 May 2022 Embargo: Immediate release In both the
12 May, 2022
SAHPRA Statement on the ANHP Judgement
EKATERINA BOLOVTSOVA via Pexels
07 May, 2022SAHPRA Comments on ACDP court matter on vaccines for minors
03 May 2022 Embargo: Immediate release Pretoria, 3
03 May, 2022SAHPRA Responds to the ANHP Judgement
20 April 2022 Embargo: Immediate release The South
19 April, 2022SAHPRA Responds to claims that hawkers are selling illicit medication in Cape Town
08 April 2022 Embargo: Immediate release The South
08 April, 2022SAHPRA clarifies the risks and benefits of the Pfizer Comirnaty vaccine
11 March 2022 Embargo: Immediate release The South
11 March, 2022SAHPRA approval of second/booster dose of the COVID-19 vaccine Janssen
23 December 2021 Embargo: Immediate release The So
08 December, 2021SAHPRA approval of booster dosing with the Pfizer (Comirnaty®) COVID-19 vaccine
8 December 2021 Embargo: Immediate release The Sou
08 December, 2021SAHPRA and the Pfizer Booster (3rd dose) Vaccine
26 November 2021 Embargo: Immediate release SAHPRA
26 November, 2021Update on the SAHPRA review of the Sputnik V Vaccine
18 October 2021 SAHPRA has been engaged in a rolli
18 October, 2021SAHPRA update on Section 21 authorisation for Pfizer Comirnaty Vaccine
10 September 2021 The South African Health Product
10 September, 2021FDA’s stance on ivermectin aligned to SAHPRA’s position
3 September 2021 The South African Health Products
03 September, 2021SAHPRA’s vaccine registration process and role of the SAHPRA Board
30 July 2021 The South African Health Products Reg
30 August, 2021A Signal Of Myocarditis / Pericarditis Associated With Pfizer-BioNTech’s Covid-19 Vaccine, Comirnaty (Bnt162b2)
26 July 2021 The South African Health Products Reg
26 August, 2021SAHPRA Statement on Adverse Events Following Immunisation (AEFIs) with COVID 19 VaccineS
20 August 2021 The South African Health Products R
20 August, 2021Health regulatory bodies condemn looting and violence targeting health care facilities
19 July 2021 As South Africa’s statutory health re
19 July, 2021SAHPRA AUTHORISES THE CORONAVAC VACCINE WITH CONDITIONS
03 July 2021 The South African Health Products Reg
03 July, 2021Media release on the approval process of Covid vaccines
01 July 2021 The South African Health Products Reg
01 July, 2021SAHPRA’s Response to the Economic Freedom Fighters (EFF) March
25 June 2021 The South African Health Products Reg
25 June, 2021SAHPRA and the Sinopharm Vaccine
23 June 2021 SAHPRA has received documentation for
23 June, 2021SAHPRA update on Vaccine Approvals
21 June 2021 The South African Health Products Reg
21 June, 2021SAHPRA update COVID-19 Vaccine Janssen – FDA Developments
13 June 2021 SAHPRA registered the Covid-19 Vaccin
13 June, 2021SAHPRA update on the COVID-19 Vaccine Janssen – GMP Concerns
7 June 2021 SAHPRA registered the Covid-19 Vaccine
07 June, 2021SAHPRA launches the Med Safety App for self-reporting of suspected Adverse Drug Reactions by the Public and Healthcare Professionals
22 April 2021 SAHPRA is pleased to announce the la
22 April, 2021
SAHPRA Refutes Claims Made by the Black Farmers Association of South Africa (BFASA)
21 April 2021 SAHPRA refutes claims made by the Pr
21 April, 2021SAHPRA Statement – Update on Sisonke Phase 3B Implementation Study
17 April 2021 SAHPRA has engaged with the Sisonke
17 April, 2021Statement by the Minister of Health, Dr Zwelini Mkhize, on the FDA’s Temporary Suspension of Johnson and Johnson vaccine rollout in the United States
13 April 2021 We have noted the decision taken by
13 April, 2021SAHPRA Statement- High Court Order – Ivermectin
9 April 2021 On 6 April 2021 the Pretoria High Cou
09 April, 2021SAHPRA registers the COVID-19 Vaccine Janssen
01 April 2021 SAHPRA registered the Covid-19 Vacci
01 April, 2021SAHPRA has NOT authorised Ivermectin for the treatment of COVID-19
29 March 2021 The SABC placed an erroneous report
29 March, 2021SAHPRA implements a new and improved online submission portal for Section 21 applications
19 March 2021 SAHPRA has implemented a new and imp
22 March, 2021SAHPRA registers Soolantra 10mg/g Cream- An ivermectin formulation
19 March 2021 On 16 March 2021 SAHPRA registered S
19 March, 2021SAHPRA and the Pfizer/Biontech Comirnaty Vaccine
16 March 2021 SAHPRA has approved the Sectio
16 March, 2021
SAHPRA and the CoronaVac Vaccine
12 March 2021 SAHPRA received documentation for th
12 March, 2021Update: SAHPRA and the SputnikV Vaccine
24 February 2021 SAHPRA has received documentation
24 February, 2021
SAHPRA and Rollout to President and Deputy President
18 February 2021 SAHPRA has approved the protocol
18 February, 2021SAHPRA clarifies its stance on Ivermectin
03 February 2021 There is an erroneous notion that
03 February, 2021
Update on the use of ivermectin in the prevention or treatment of COVID-19
28 January 2021 The second wave of the COVID-19 ep
28 January, 2021SAHPRA AUTHORISES COVISHIELD – AN ADENOVIRUS-VECTORED VACCINE FOR THE PREVENTION OF COVID-19
27 January 2021 In an effort to enable and support
27 January, 2021SAHPRA will commence review of vaccine applications for registration for COVID-19
15 December 2020 With the advent of COVID-19, vacc
15 December, 2020
SAHPRA’s Response to Medical Brief article
12 November 2020 SAHPRA wishes to correct the inac
12 November, 2020
SAHPRA REFUTES CLAIMS BY THE BLACK FARMERS ASSOCIATION
20 October 2020 SAHPRA refutes claims made by the
20 October, 2020SAHPRA’S STANCE ON THE ANHP JUDGEMENT
On 01 October 2020, the Pretoria High Court delive
12 October, 2020COVID-19 – THE APPROPRIATE PLACE FOR RAPID TEST KITS
30 March 2020 In line with the recommendation of t
30 March, 2020
THE USE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH COVID-19
The South African Health Products Regulatory Autho
25 March, 2020
SAHPRA and Law Enforcement seize illegal products
The South African Health Products Regulatory Autho
13 December, 2019
Metformin – Under Investigation regarding the possible contamination by NDMA
The South African Health Products Regulatory Autho
12 December, 2019
SAPS AND SAHPRA
The South African Police Service is issuing a ster
04 November, 2019SAHPRA FINAL MEDIA RELEASE UPDATE ON RANITIDINE CONTAINING MEDICINES
The South African Health Products Regulatory Autho
29 October, 2019
CANNABIS AND RELATED SUBSTANCES
Between 60 and 100 chemicals called cannabinoids a
25 October, 2019
SAHPRA AND SIU
In February 2019 the South African Health Products
19 October, 2019
Cannabis Licensing
The South African Health Products Regulatory Autho
14 October, 2019RANITIDINE CONTAINING MEDICINES UPDATE
The South African Health Products Regulatory Autho
12 October, 2019
MEET THE SAHPRA CEO
SAHPRA is pleased to announce the appointment of a
08 October, 2019
Mr Khamusi Mutoti appointed Chairperson of African Blood Regulator’ Forum (ABRF)
Mr Khamusi Mutoti, Biological Medicine Manager at
07 October, 2019
